-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Wave Life Sciences, Raises Price Target to $44

Benzinga·10/29/2026 22:10:05
Canaccord Genuity analyst Whitney Ijem maintains Wave Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $42 to $44.